Category
Primary
heart-and-cardiovascular-diseases · embed-ft 0.6
Tree path
Medical Health › Diseases and Conditions › Heart and Cardiovascular Diseases
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
Heart Failure Treatment | INPEFA® (sotagliflozin) HCP
Description
INPEFA® is an inhibitor of SGLT2 and SGLT1 for adults with heart failure or T2 Diabetes, CKD, and other CV risk factors. See Safety Info and full Prescribing Information.
Final URL
https://www.inpefahcp.com/?utm_source=JAFFHF_journal&utm_medium=vanity+url&utm_campaign=now+approved
Language
en (html)
Scanned at
2026-06-16 15:26:10